Navigation Links
Celsion Receives Fast Track Designation for ThermoDox® Development Program to Treat Primary Liver Cancer
Date:8/24/2010

74; is being evaluated in a 600 patient global Phase III study at 75 clinical sites under an FDA Special Protocol Assessment. The study is designed to evaluate the efficacy of ThermoDox in combination with RFA when compared to patients who receive RFA alone as the control. The primary endpoint for the study is progression-free survival and enrollment is expected to be completed by year end 2010.  For recurrent chest wall breast cancer, ThermoDox® is being evaluated in a pivotal Phase I/II open-label, dose-escalating trial that is designed to measure durable local complete response at the tumor site. Celsion expects to enroll approximately 100 patients across the United States and to complete the study by the first half of 2011. Additional information on the Company's ThermoDox® clinical studies may be found at http://www.clinicaltrials.gov

About CelsionCelsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems. Celsion has research, license, or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, Cleveland Clinic, and the North Shore Long Island Jewish Health System.

For more information on Celsion, visit our website: http://www.celsion.com.

Celsion wishes to inform readers that forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that such forward-looking statements involve risks and uncertainties inc
'/>"/>

SOURCE Celsion Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Celsion Announces CFO Departure
2. Quest Diagnostics Care360™ EHR Module Receives Preliminary ARRA IFR Stage 1 Certification
3. Hospira Japan Receives Approval for New Indication for Precedex IV™ 200ug
4. EntreMed Receives NASDAQ Listing Rule 5550(b)(2) Determination Letter
5. Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules
6. KemPharm, Inc. Receives Notice of Issuance From USPTO on Patent Protecting Companys ADHD Prodrug Technology
7. PDL BioPharma Receives Letter from Genentech Relating to European Patents
8. Sigma-Aldrich® Receives National Institutes of Health Funding for Cardiovascular Disease Research
9. PolyGel® Receives SADMERC Approval for L-Code L3670 for ThermoActive™ Cold & Hot Mobile Compression Shoulder Orthosis
10. Accurays CyberKnife® G4 System Receives Shonin Approval
11. AdvanDx Receives FDA 510(k) Clearance for 90 Minutes Protocol for Yeast Traffic Light® PNA FISH®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014 Orexigen® Therapeutics, Inc. (Nasdaq: ... quarter 2014, on Thursday, August 7, 2014 before markets ... webcast and conference call at 8:00 a.m. Eastern time ... host the call and webcast to discuss financial results ... accessed by calling (800) 708-4540 (domestic) or (847) 619-6397 ...
(Date:7/31/2014)... -- Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" or the ... consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), health ... signing of its first distributor for its new Cordyceps ... Hubei Province located in the ... The contract with the new distributor, ...
(Date:7/31/2014)... -- Northsight Capital, Inc. (OTCBB: NCAP) announced today that businessman ... of the company. Mr. Bluher has extensive experience in ... investment banking. Mr. Bluher has over 15 years of ... Wall Street, Mr. Bluher was also Senior Counsel in ... Commission in Washington D.C.   ...
Breaking Medicine Technology:Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 2Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 2Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 3Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 4Northsight Capital, Inc. Names Wall Street Veteran John Bluher, Former EVP And General Counsel Of Knight Trading Group, Chairman And CEO. 2
... April 20, 2012  In a time of rapid ... rethinking their use of technology, applications and workflow. ... for health and human services organizations nationwide, today ... help providers deliver accountable, recovery-based care in the ...
... April 20, 2012 There are some two dozen oncology ... earlier stages of development. While only some of these therapies ... yet another hurdle: a competitive marketplace where success revolves around ... environment, pharmaceutical organizations in the oncology therapeutic area must constantly ...
Cached Medicine Technology:Netsmart's Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment 2Netsmart's Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment 3Netsmart's Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment 4Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector 2
(Date:7/31/2014)... Vegas, NV (PRWEB) July 31, 2014 ... to helping independent pharmacies enhance patient care by ... compliance and medication adherence. The first of many ... the opening of ThoughtSpot 2014, Good Neighbor Pharmacy ... for Medicare and Medicaid Services (CMS) Star Measures ...
(Date:7/31/2014)... 2014 The controversy surrounding uterine ... notes that Johnson & Johnson’s Ethicon, Inc. unit ... its power morcellators ( http://www.gynecaremorcellatorlawsuit.com/ ) from the ... company said it decided to do so because ... remain uncertain.* , “In light of mounting evidence ...
(Date:7/31/2014)... 31, 2014 Model moms are believers. PBS ... reports positions in the field have grown exponentially in the ... any thriving industry, there are associated myths that need to ... is Frontier Nursing University . Celebrating 75 years in ... program in the nation. “Frontier is changing the face ...
(Date:7/31/2014)... Clifton Dental Associates is now proud ... fluoride treatments to their adult patients to aid in ... sensitivity in patients that exhibit symptoms. Dental caries, ... commonly known as “tooth decay” or a “cavity.” This ... , Fluoride therapy is the delivery of ...
(Date:7/31/2014)... The July 2014 issue of ... an open access journal featuring the following articles:, ... generating multicomponent , Graphene veils: A ... A workflow to increase verification rate of chromosomal ... Quantification of particle-conjugated or particle-encapsulated peptides on ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 2Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 3Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 2Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 3Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 2Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 3Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 4Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 5Health News:NJ Top Dentists Approved, Clifton Dental Associates Now Actively Recommending the Application of Topical Fluoride Treatments to Adults 2Health News:BioTechniques: The International Journal of Life Science Methods Announces the Publication of the July 2014 Issue—Available in Print and Online as an Open Access Journal 2Health News:BioTechniques: The International Journal of Life Science Methods Announces the Publication of the July 2014 Issue—Available in Print and Online as an Open Access Journal 3
... Dr. Khanna wants to thank ... in a row. , ... 2010 -- Repeat is sure sweet. Dr. Khanna and The Khanna Institute of Lasik & ... LASIK surgeon by the readers of the Ventura County Star. This achievement is notably recognized and ...
... tie-in to tremors and other motor problems , ... how a mutation in a gene called LRRK2 may ... , In experiments using genetically engineered mice, the Mount ... dopamine transmission and controls motor performance. Dopamine is a ...
... Calif.Scientists from the California Institute of Technology (Caltech) have ... key proteingp120found on the surface of a specific subgroup ... demonstrated that a particular antibody to gp120 makes contact ... receptor that gp120 uses to gain entrance into the ...
... Treatment Service has been named a "Clinical Center of Excellence" ... upon five pain centers each year. This is the first ... are honored to be named a Clinical Center of Excellence ... chief of the pain management department at Children,s. "Everyone in ...
... too , FRIDAY, April 2 (HealthDay News) -- Death can ... own death, or that of a loved one. , Yet ... information from such talks, people can make sure that their ... followed when it,s most crucial. , "It,s very important to ...
... , ... According to a survey conducted by the Greater New England ... that they were supportive of the recently passed health care reform legislation. ... themselves and their employees. The survey also found that 61 percent ...
Cached Medicine News:Health News:Dr. Rajesh Khanna Selected as Best Lasik Surgeon Two Years in a Row 2Health News:Caltech scientists uncover structure of key protein in common HIV subgroup 2Health News:Caltech scientists uncover structure of key protein in common HIV subgroup 3Health News:Start Talking About Life's End Well in Advance 2Health News:Start Talking About Life's End Well in Advance 3Health News:Minority Businesses Support Health Care Reform Legislation, According to Survey 2
Bio-Rad's Genetic Systems™ HBsAg EIA 3.0 screening and confirmatory assays offer outstanding sensitivity and early detection of HBV infection, helping to meet your testing criteria....
... Cryo System is the first in portability and performance. ... surgeons who need a flexible, portable system with the ... CTU attaches easily to an "E" size tank and ... cryo to where it is needed.,The CTU Travel Case ...
The most compact revolutionary innovation in hematology. 3 Part DIFF + CRP measurement on whole blood....
The most compact revolutionary innovation in hematology. 26 parameters with 5 Part DIFF...
Medicine Products: